Nucleic Acid Isolation And Purification Market Worth $9.8 Billion By 2028

The global nucleic acid isolation and purification market accounted for 4.1 billion in 2020 and is projected to exhibit a CAGR of 11.4% from 2021 to 2028. The market is primarily driven by the increasing popularity of sequencing techniques in clinical diagnostics, key developments in growth in enzymology and genomics-based studies, and rising R&D investments pertaining to precision medicine and molecular biology.

A global pandemic caused by the SARS-CoV-2 in China in late 2019 swiftly fueled the demand for affordable, effective diagnostic tests that could be used in both non-clinical and clinical settings. The leading manufacturers increased their business capacities as a result of the rising demand for nucleic acid extraction kits. For instance, QIAGEN said in March 2020 that by the end of the year, it would increase its production capacity in the U.S. and Europe to 20 million patient tests per month.

Furthermore, it is crucial for the management of COVID-19 to provide rapid diagnoses, efficient treatments, and long-term preventative strategies. A new frontier in diagnostic innovation has been opened up by the present competition to launch affordable point-of-contact test kits and successful laboratory procedures for the optimal COVID-19 diagnosis. The boom in the use of PCR tests is aiding the market growth and nucleic acid isolation and purification technology is a crucial stage in the PCR workflow. 

 To request a sample copy or view summary of this report, "please" click the link below:

 https://www.millioninsights.com/industry-reports/global-nucleic-acid-isolation-purification-market

Nucleic Acid Isolation And Purification Market Report Highlights

• The kits and reagents segment led the market in 2020, accounting for a revenue share of 76.0% due to the increasing number of R&D studies that are focused on rare genome-based diseases

• The instruments segment is anticipated to witness the fastest growth rate of 12.6% by 2028 and is attributed to rapid technological innovation and the adoption of automated Nucleic Acid Isolation and Purification (NAIP) instruments

• The RNA isolation and purification type segment captured the largest market share of 53.6% in 2020 and the DNA isolation and purification type segment is estimated to exhibit a CAGR of 13.5% by 2028

• The hospitals and diagnostic centers emerged as the leading end-use segment in 2020, accounting for a share of 33.6% in 2020 and the pharmaceutical and biotechnology companies are set to showcase the fastest CAGR of 11.8% in the forthcoming years

• Geographically, North America held the largest market share of over 36.7% in 2020 and APAC is the fastest-growing region due to factors such as extensive research in life sciences, rising economic growth, growing patient base in India, China, and Japan, the presence of some top biotech companies, and supportive government initiatives 

Nucleic Acid Isolation And Purification Market Segments

Nucleic Acid Isolation & Purification Product Outlook (Revenue, USD Million, 2017 - 2028)
    • Kits & Reagents
    • Instruments

Nucleic Acid Isolation & Purification Type Outlook (Revenue, USD Million, 2017 - 2028)
    • DNA Isolation & Purification (I&P)
        • Genomic DNA I&P
        • Plasmid DNA I&P
        • Viral DNA I&P
        • Other
    • RNA Isolation & Purification
        • miRNA Isolation & Purification
        • mRNA Isolation & Purification
        • Total RNA Isolation & Purification
        • Other

Nucleic Acid Isolation & Purification Method Outlook (Revenue, USD Million, 2017 - 2028)
    • Column-based
    • Magnetic Beads
    • Reagent-based
    • Others

Nucleic Acid Isolation & Purification Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Precision Medicine
    • Diagnostics
    • Drug Discovery & Development
    • Agriculture and Animal Research
    • Other Applications

Nucleic Acid Isolation & Purification End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Academic Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Hospitals and Diagnostic Centers
    • Other End-use

Nucleic Acid Isolation & Purification Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
    • Asia Pacific
        • China
        • Japan
    • Latin America
        • Brazil
        • Mexico
    • Middle East and Africa (MEA)
        • South Africa

List of Key Players in the Nucleic Acid Isolation And Purification Market
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Danaher
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc.
    • Takara Bio, Inc.
    • Promega Corporation
    • New England Biolabs
    • LGC Limited
    • Abcam plc
    • Norgen Biotek Corp
    • AutoGen, Inc.
    • Biogenuix
    • PCR Biosystems, Inc.
    • MagGenome
    • Apical Scientific Sdn. Bhd
    • MACHEREY-NAGEL GmbH & Co. KG